Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · July 20, 2022

Vitamin D Insufficiency Is a Paclitaxel-Induced Peripheral Neuropathy Risk Factor in Early-Stage Breast Cancer

Journal of Clinical Oncology


Additional Info

Journal of Clinical Oncology
Vitamin D insufficiency as a peripheral neuropathy risk factor in white and black patients in SWOG 0221
J. Clin. Oncol 2022 Jun 01;40(no. 16_suppl)12023-12023, CS Chen, G Zirpoli, S McCann, et al

Further Reading